Carregant...
Enriched pharmacokinetic behavior and antitumor efficacy of thymoquinone by liposomal delivery
BACKGROUND: Thymoquinone (TQ) has potential anti-inflammatory, immunomodulatory and anticancer effects but its clinical use is limited by its low solubility, poor bioavailability and rapid clearance. AIM: To enhance systemic bioavailability and tumor-specific toxicity of TQ. MATERIALS & METHODS:...
Guardat en:
| Publicat a: | Nanomedicine (Lond) |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Future Medicine Ltd
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8173500/ https://ncbi.nlm.nih.gov/pubmed/33769068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nnm-2020-0470 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|